文献速递冠心病

PET心肌灌注绝对定量检测非阻塞性冠脉患者冠脉微血管病的价值

[Value of absolute quantification of myocardial perfusion by PET in detecting coronary microvascular disease in patients with non-obstructive coronaries].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2020-01-01

回顾性分析97例心绞痛患者,比较非阻塞组(72例)与阻塞组(25例)非阻塞性冠脉的CMVD发生情况。血管层面阻塞组非阻塞性冠脉CMVD比例高于非阻塞组(47.1%比25.5%,P=0.009),患者层面两组无统计学差异。两组CMVD冠脉支配区RMBF、SMBF及CFR均相似。

要点

  • 阻塞性冠脉病患者非阻塞性冠脉的CMVD检出率显著高于非阻塞性冠脉病患者。
  • 患者层面两组CMVD发生率无统计学差异。
  • 两组CMVD严重程度(RMBF、SMBF、CFR)基本一致。

核心结论

  • 非阻塞与阻塞性冠脉疾病患者的非阻塞性冠脉均可存在CMVD,后者CMVD检出率更高,两者CMVD严重程度基本一致。

研究设计与样本

  • 回顾性分析97例疑诊CMVD的心绞痛患者,均完成(13)N-氨水PET心肌血流绝对定量检查并在90天内完成冠脉造影或CTA。
  • 按冠脉狭窄程度分为非阻塞组(72例,3支冠脉均无狭窄≥50%)和阻塞组(25例,至少1支狭窄≥50%且至少1支狭窄<50%)。

主要发现

  • 血管层面阻塞组非阻塞性冠脉CMVD比例高于非阻塞组[47.1%(16/34)比25.5%(55/216),χ²=6.738,P=0.009]。
  • 患者层面两组CMVD比例无统计学差异[44%(11/25)比33.3%(24/72),χ²=0.915,P=0.339]。
  • 两组CMVD冠脉支配区RMBF[(0.83±0.14)比(0.82±0.17)ml·min⁻¹·g⁻¹]、SMBF[(2.13±0.60)比(1.91±0.50)ml·min⁻¹·g⁻¹]及CFR(2.59±0.66比2.36±0.47)差异均无统计学意义(P>0.05)。

关键数值与推荐

  • CMVD判定标准为CFR<2.90且SMBF<2.17 ml·min⁻¹·g⁻¹。
  • 非阻塞组定义为3支冠脉均不存在狭窄≥50%的病变;阻塞组定义为至少存在1支冠脉狭窄≥50%且至少存在1支冠脉狭窄<50%。

临床怎么用

  • 对阻塞性冠脉病患者,除评估阻塞病变外,应关注非阻塞性冠脉的CMVD可能。
  • PET心肌灌注绝对定量(CFR、SMBF)可用于检出非阻塞性冠脉的CMVD。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare the incidence of coronary microvascular disease (CMVD) between patients with non-obstructive and obstructive coronary arteries. Methods: We retrospectively analyzed 97 patients with angina pectoris, who underwent the absolute quantitative PET examination of myocardial perfusion and coronary anatomy examination within 90 days. All patients were divided into two groups: non-obstructive group (72 cases, no stenosis ≥50% in all three coronary arteries) and obstructive group (25 cases, at least one coronary stenosis ≥50%; and at least one coronary stenosis<50%). Quantitative parameters derived from PET including rest myocardial blood flow (RMBF), stress myocardial blood flow (SMBF), coronary flow reserve (CFR) and cardiovascular risk factors were compared between the two groups. CMVD was defined as CFR<2.90 and SMBF<2.17 ml·min(-1)·g(-1). Results: Incidence of CMVD was significant higher in the non-obstructive coronary arteries of the obstructive group than in the non-obstructive coronary arteries of non-obstructive group (47.1% (16/34) vs. 25.5% (55/216), χ(2)=6.738, P=0.009) while incidence of CMVD was similar between non-obstructive and obstructive patients ((44% (11/25) vs. 33.3% (24/72), χ(2)=0.915, P=0.339). RMBF ((0.83±0.14) ml·min(-1)·g(-1) vs. (0.82±0.17) ml·min(-1)·g(-1)), SMBF ((2.13±0.60) ml·min(-1)·g(-1) vs. (1.91±0.50) ml·min(-1)·g(-1)) and CFR (2.59±0.66 vs. 2.36±0.47) were similar between the two groups (all P>0.05). Conclusions: CMVD can occur in non-obstructive coronary arteries in both patients with non-occlusive coronary arteries and patients with obstructive coronary arteries. Prevalence of CMVD is significantly higher in patients with obstructive coronary arteries than in patients with non-obstructive coronary arteries. The CMVD severity is similar between the two groups. 目的: 比较非阻塞及阻塞性冠状动脉(冠脉)疾病患者的冠脉微血管疾病(CMVD)发生情况。 方法: 回顾性分析2015年12月至2019年12月在山西医科大学附属第一医院成功完成(13)N-氨水正电子发射计算机断层显像(PET)心肌血流绝对定量检查并在PET检查90 d内完成冠脉造影或CTA的97例疑诊CMVD患者,根据造影及CTA结果将患者分为非阻塞组(72例,3支冠脉均不存在狭窄≥50%的病变)和阻塞组(25例,至少存在1支冠脉狭窄≥50%,且至少存在1支冠脉狭窄<50%),以冠脉血流储备(CFR)<2.90且负荷心肌血流量(SMBF)<2.17 ml·min(-1)·g(-1)为CMVD的判定标准,从血管及患者层面分析两组患者非阻塞性冠脉的CMVD发生情况,并比较两组间发生CMVD的冠脉支配区的静息心肌血流量(RMBF)、SMBF及CFR。 结果: 在血管层面,阻塞组非阻塞性冠脉存在CMVD的比例高于非阻塞组[47.1%(16/34)比25.5%(55/216),χ(2)=6.738,P=0.009]。在患者层面,两组发生CMVD的比例差异无统计学意义[(44%(11/25)比33.3%(24/72),χ(2)=0.915,P=0.339]。两组间发生CMVD的冠脉支配区的RMBF[(0.83±0.14)ml·min(-1)·g(-1)比(0.82±0.17)ml·min(-1)·g(-1)]、SMBF[(2.13±0.60)ml·min(-1)·g(-1)比(1.91±0.50)ml·min(-1)·g(-1)]及CFR(2.59±0.66比2.36±0.47)比较,差异均无统计学意义(P>0.05)。 结论: 非阻塞与阻塞性冠脉疾病患者的非阻塞性冠脉均可存在CMVD,后者的CMVD检出率更高,两者CMVD的严重程度基本一致。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wu P, Guo XS, Zhang X, et al. [Value of absolute quantification of myocardial perfusion by PET in detecting coronary microvascular disease in patients with non-obstructive coronaries]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32234177. doi:10.3760/cma.j.cn112148-20191024-00652

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。